3 Super-Defensive Shares I’d Buy With £10,000: United Utilities Group PLC, Unilever plc And AstraZeneca plc

Here’s why United Utilities Group PLC (LON: UU), Unilever plc (LON: ULVR) and AstraZeneca plc (LON: AZN) could protect your portfolio against a market fall

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

cityAlthough the FTSE 100 has vast potential to make further gains, so-called ‘black swans’ can appear. These are essentially unforeseen events that can have a negative impact on share prices and, as such, it’s common sense for portfolios to have exposure to companies that are unlikely to be hit quite as hard as the wider index in the event of a severe market fall.

With that in mind, here are three super-defensive shares that I’d buy with £10,000.

United Utilities

It’s been a fantastic year for investors in United Utilities (LSE: UU) with the north-west based water company seeing its share price rise by 34% over the course of 2014, while the FTSE 100 is up just 1% over the same time period. As a provider of water services, United Utilities has a product that is about as defensive as you can get and it can be stated that demand for water is likely to remain steady and stable over the long run. This means that earnings should be far more predictable than many of its peers, and the 4.2% yield should remain consistent over the longer term, too. Furthermore, with it having a beta of just 0.4, a fall of 1% in the wider market should mean (in theory) that shares in United Utilities suffer only a 0.4% drop.

Unilever

Although many of its products are described as being ‘discretionary’, purchasers of Unilever’s (LSE: ULVR) (NYSE: UL.US) products may argue that in recent years they have become necessities. For instance, various luxury personal care and food products enjoy a staggering amount of customer loyalty and many purchasers would rather forego or trade down on other products than on their favourite brand of shampoo or skin care cream. This means that Unilever’s earnings profile is far more predictable and stable than many of its index peers.

In addition, Unilever has a huge geographical spread and a large portfolio of products, which means that changes in tastes or challenges in one part of the globe are unlikely to hit it too hard. Furthermore, with a beta of 0.8 Unilever could outperform a falling index.

AstraZeneca

AstraZeneca’s (LSE: AZN) (NYSE: AZN.US) earnings profile is currently highly volatile. That’s because it is experiencing a patent cliff, where many of its blockbuster drugs are coming under attack from generic competition. However, the company is making progress in replacing these key drugs and could have a bright future. In addition, it could prove to be a great defensive play because it has a beta of 0.8 and also because demand for its products is unlikely to change significantly – even during a recession. Indeed, the products that AstraZeneca sells and is hoping to sell are likely to see constantly rising demand over the years as illnesses such as diabetes become more prevalent. This means better revenue and earnings visibility for shareholders and makes the stock a prudent defensive play.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and United Utilities Group. The Motley Fool recommends Unilever. The Motley Fool owns shares of Unilever.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »